These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29339436)

  • 1. Rewired Notch/p53 by Numb'ing Mdm2.
    Kim H; Ronai ZA
    J Cell Biol; 2018 Feb; 217(2):445-446. PubMed ID: 29339436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Numb-Mdm2 fuzzy complex reveals an isoform-specific involvement of Numb in breast cancer.
    Colaluca IN; Basile A; Freiburger L; D'Uva V; Disalvatore D; Vecchi M; Confalonieri S; Tosoni D; Cecatiello V; Malabarba MG; Yang CJ; Kainosho M; Sattler M; Mapelli M; Pece S; Di Fiore PP
    J Cell Biol; 2018 Feb; 217(2):745-762. PubMed ID: 29269425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUMB controls p53 tumour suppressor activity.
    Colaluca IN; Tosoni D; Nuciforo P; Senic-Matuglia F; Galimberti V; Viale G; Pece S; Di Fiore PP
    Nature; 2008 Jan; 451(7174):76-80. PubMed ID: 18172499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
    Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
    FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation among Numb, MDM2 and p53 in the development and progression of pancreatic cancer.
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Cell Tissue Res; 2013 Nov; 354(2):521-32. PubMed ID: 23881403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating the regulator: Numb acts upstream of p53 to control mammary stem and progenitor cell.
    Faraldo MM; Glukhova MA
    J Cell Biol; 2015 Nov; 211(4):737-9. PubMed ID: 26598611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for Numb in p53 stabilization.
    Carter S; Vousden KH
    Genome Biol; 2008; 9(5):221. PubMed ID: 18492217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of breast cancer outcome with status of p53 and MDM2 SNP309.
    Boersma BJ; Howe TM; Goodman JE; Yfantis HG; Lee DH; Chanock SJ; Ambs S
    J Natl Cancer Inst; 2006 Jul; 98(13):911-9. PubMed ID: 16818855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers.
    Abdel-Fatah TM; Powe DG; Agboola J; Adamowicz-Brice M; Blamey RW; Lopez-Garcia MA; Green AR; Reis-Filho JS; Ellis IO
    J Pathol; 2010 Mar; 220(4):419-34. PubMed ID: 20044801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression.
    Beverly LJ; Felsher DW; Capobianco AJ
    Cancer Res; 2005 Aug; 65(16):7159-68. PubMed ID: 16103066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer.
    Agrawal A; Yang J; Murphy RF; Agrawal DK
    Exp Mol Pathol; 2006 Oct; 81(2):115-22. PubMed ID: 16919268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human MDM2 isoforms translated differentially on constitutive versus p53-regulated transcripts have distinct functions in the p53/MDM2 and TSG101/MDM2 feedback control loops.
    Cheng TH; Cohen SN
    Mol Cell Biol; 2007 Jan; 27(1):111-9. PubMed ID: 17060450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B e antigen and its precursors promote the progress of hepatocellular carcinoma by interacting with NUMB and decreasing p53 activity.
    Liu D; Cui L; Wang Y; Yang G; He J; Hao R; Fan C; Qu M; Liu Z; Wang M; Chen L; Li H; Guo D
    Hepatology; 2016 Aug; 64(2):390-404. PubMed ID: 27106262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of p53-MDM2 auto-regulatory pathway in breast carcinoma.
    Baliou E; Nonni A; Keramopoulos D; Ragos V; Tsiambas E; Patsouris E; Pavlakis K
    J BUON; 2016; 21(5):1099-1103. PubMed ID: 27837610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor promotion by Mdm2 splice variants unable to bind p53.
    Fridman JS; Hernando E; Hemann MT; de Stanchina E; Cordon-Cardo C; Lowe SW
    Cancer Res; 2003 Sep; 63(18):5703-6. PubMed ID: 14522887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol.
    Saji S; Nakashima S; Hayashi S; Toi M; Saji S; Nozawa Y
    Jpn J Cancer Res; 1999 Feb; 90(2):210-8. PubMed ID: 10189892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.
    Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM
    Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway.
    Kundu N; Brekman A; Kim JY; Xiao G; Gao C; Bargonetti J
    Oncotarget; 2017 Jul; 8(29):47916-47930. PubMed ID: 28615518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.